当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:65.17亿  总市值:66.36亿
流通股本:12.85亿   总股本:13.09亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金37,340,831,696.623,954,906,028.5611,168,439,682.9856,225,650,992.59
  收到的税费返还---11,072,232.76
  收到其他与经营活动有关的现金146,683,981.3578,103,694.17816,533,656.17349,299,958.55
  经营活动现金流入小计37,487,515,677.9524,033,009,722.7311,984,973,339.1556,586,023,183.9
  购买商品、接受劳务支付的现金40,357,961,259.1326,548,798,231.7414,888,756,059.8251,301,372,909.69
  支付给职工以及为职工支付的现金786,375,678.4530,465,484.25316,652,576.08978,903,680.85
  支付的各项税费766,154,612.63499,428,560.39271,568,974.91,017,753,815.05
  支付其他与经营活动有关的现金553,758,596.04485,797,186.73108,434,853.751,152,227,362.91
  经营活动现金流出小计42,464,250,146.228,064,489,463.1115,585,412,464.5554,450,257,768.5
  经营活动产生的现金流量净额-4,976,734,468.25-4,031,479,740.38-3,600,439,125.42,135,765,415.4
二、投资活动产生的现金流量:
  收回投资收到的现金959,000,000827,000,000--
  取得投资收益收到的现金4,252,843.681,929,902.12690,965.483,342,990.32
  处置固定资产、无形资产和其他长期资产收回的现金净额6,964,687.536,987,749.35279,461.487,091,022.1
  投资活动现金流入小计970,217,531.21835,917,651.47970,426.9610,434,012.42
  购建固定资产、无形资产和其他长期资产支付的现金177,192,879.45140,494,57167,566,651.24544,760,104.06
  投资支付的现金1,249,000,000909,000,000-27,600,000
  支付其他与投资活动有关的现金--340,000,000-
  投资活动现金流出小计1,426,192,879.451,049,494,571407,566,651.24572,360,104.06
  投资活动产生的现金流量净额-455,975,348.24-213,576,919.53-406,596,224.28-561,926,091.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金35,007,74533,007,745-76,718,200
  其中:子公司吸收少数股东投资收到的现金35,007,74533,007,745-76,718,200
  取得借款收到的现金12,910,163,704.2510,854,009,962.086,363,293,333.3416,602,282,765.41
  发行债券收到的现金5,572,528,735.854,072,528,735.851,000,000,0004,499,887,500
  收到其他与筹资活动有关的现金39,406,74039,406,7401,072,528,735.85-
  筹资活动现金流入小计18,557,106,925.114,998,953,182.938,435,822,069.1921,178,888,465.41
  偿还债务支付的现金14,282,441,596.1211,435,874,062.15,492,282,857.2521,282,875,173.96
  分配股利、利润或偿付利息支付的现金545,736,766.77433,594,400.09138,936,694.1617,744,311.24
  其中:子公司支付给少数股东的股利、利润108,624,768.8461,287,650.74-112,919,162.84
  支付其他与筹资活动有关的现金132,351,136.49132,351,136.4923,820,688.23118,040,978.28
  筹资活动现金流出小计14,960,529,499.3812,001,819,598.685,655,040,239.5822,018,660,463.48
  筹资活动产生的现金流量净额3,596,577,425.722,997,133,584.252,780,781,829.61-839,771,998.07
五、现金及现金等价物净增加额-1,836,132,390.77-1,247,923,075.66-1,226,253,520.07734,067,325.69
  加:期初现金及现金等价物余额2,928,136,456.552,928,136,456.552,928,136,456.552,194,069,130.86
  期末现金及现金等价物余额1,092,004,065.781,680,213,380.891,701,882,936.482,928,136,456.55
补充资料:
  净利润-379,749,529.44-743,119,993.89
  资产减值准备-3,827,050.29-18,267,214.45
  固定资产和投资性房地产折旧-65,052,348.09-121,628,563.95
  无形资产摊销-16,951,279.85-32,395,107.97
  长期待摊费用摊销-10,094,817.03-16,549,417.6
  处置固定资产、无形资产和其他长期资产的损失--8,651,959.87--3,852,284.16
  固定资产报废损失-152,490.76--
  公允价值变动损失--383,768.34--
  财务费用-144,985,507.7-326,276,767.48
  投资损失-1,476,139.27--4,018,269.49
  递延所得税--17,984,015.96--21,232,042.7
  其中:递延所得税资产减少--18,525,961.89--20,464,353.97
    递延所得税负债增加-541,945.93--767,688.73
  存货的减少-125,974,414.8--502,369,276.16
  经营性应收项目的减少--4,839,595,497.73-454,046,005.51
  经营性应付项目的增加--54,651,329.85-790,191,969.63
  现金的期末余额-1,680,213,380.89-2,928,136,456.55
  减:现金的期初余额-2,928,136,456.55-2,194,069,130.86
  现金及现金等价物的净增加额--1,247,923,075.66-734,067,325.69
公告日期2025-10-312025-08-302025-04-302025-04-10
审计意见(境内)标准无保留意见
TOP↑